全文获取类型
收费全文 | 936011篇 |
免费 | 68058篇 |
国内免费 | 1667篇 |
专业分类
耳鼻咽喉 | 13073篇 |
儿科学 | 24461篇 |
妇产科学 | 23336篇 |
基础医学 | 133500篇 |
口腔科学 | 28295篇 |
临床医学 | 81356篇 |
内科学 | 183892篇 |
皮肤病学 | 19257篇 |
神经病学 | 72584篇 |
特种医学 | 36975篇 |
外国民族医学 | 83篇 |
外科学 | 152617篇 |
综合类 | 18776篇 |
现状与发展 | 1篇 |
一般理论 | 234篇 |
预防医学 | 62091篇 |
眼科学 | 21464篇 |
药学 | 73206篇 |
4篇 | |
中国医学 | 2399篇 |
肿瘤学 | 58132篇 |
出版年
2018年 | 9124篇 |
2017年 | 7185篇 |
2016年 | 7926篇 |
2015年 | 9057篇 |
2014年 | 12282篇 |
2013年 | 17771篇 |
2012年 | 24447篇 |
2011年 | 25466篇 |
2010年 | 15080篇 |
2009年 | 14452篇 |
2008年 | 24878篇 |
2007年 | 26029篇 |
2006年 | 26799篇 |
2005年 | 25752篇 |
2004年 | 24811篇 |
2003年 | 23816篇 |
2002年 | 23371篇 |
2001年 | 54835篇 |
2000年 | 56675篇 |
1999年 | 47124篇 |
1998年 | 10834篇 |
1997年 | 9577篇 |
1996年 | 9685篇 |
1995年 | 9021篇 |
1994年 | 8363篇 |
1993年 | 7665篇 |
1992年 | 35558篇 |
1991年 | 33970篇 |
1990年 | 32789篇 |
1989年 | 31924篇 |
1988年 | 29026篇 |
1987年 | 28277篇 |
1986年 | 26313篇 |
1985年 | 25164篇 |
1984年 | 17853篇 |
1983年 | 15157篇 |
1982年 | 7806篇 |
1981年 | 6779篇 |
1979年 | 15795篇 |
1978年 | 10606篇 |
1977年 | 9061篇 |
1976年 | 7874篇 |
1975年 | 8631篇 |
1974年 | 10470篇 |
1973年 | 9862篇 |
1972年 | 9360篇 |
1971年 | 8854篇 |
1970年 | 8430篇 |
1969年 | 7927篇 |
1968年 | 7201篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
41.
42.
目的 分析社区"5+1"糖尿病分阶段达标管理对2型糖尿病患者生存质量的干预效果及其影响因素,为提高患者生存质量提供依据。方法 采用分层整群抽样的方法在山西省、江苏省和宁夏回族自治区选择12个社区卫生服务中心,分别作为干预组(管理方式:社区"5+1"糖尿病分阶段达标管理)、对照组[管理方式:依据《国家基本公共卫生服务规范(2011年版)》的相关要求],进行为期2年的随访观察。采用面对面问卷调查的方式,收集患者的人口学信息等基本信息;采用健康调查简表(SF-36)对患者在干预前后测量生存质量。采用SAS 9.4软件进行双重差分法以及多重线性回归模型分析。结果 基线时共纳入2 467名研究对象,终末时共1 924人接受了为期2年完整的随访管理。干预后,干预组、对照组患者生理健康维度(PCS)、心理健康维度(MCS)评分变化净差值分别为13.6分、29.8分。多重线性回归分析结果显示,影响患者PCS得分的主要因素有年龄、医保类型、基线PCS得分以及所在地区,影响患者MCS得分的主要因素有年龄、医保类型、基线MCS得分、是否合并高血压以及所在地区。结论 社区"5+1"糖尿病分阶段达标管理对2型糖尿病患者生存质量的干预效果较好。 相似文献
43.
A case of bullous pemphigoid associated with psoriasis vulgaris showing Hailey–Hailey disease‐like histopathological changes in regenerated epidermis without genomic mutation in ATP2C1 or ATP2A2 gene
下载免费PDF全文
![点击此处可从《Journal of the European Academy of Dermatology and Venereology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
44.
F. Fruzzetti G. Palla A. Sbrana T. Simoncini M. R. Sessa 《Gynecological endocrinology》2020,36(10):938-940
AbstractObjective: To understand the origin of extremely high gonadotropin levels in a perimenopausal woman.Methods: A 52-year-old woman with a 2?months of amenorrhea followed spontaneous menstrual cycles recovery was referred to our outpatient clinic with elevated follicle-stimulating hormone (FSH, 483 mUI/ml), luteinizing hormone (LH, 475 mUI/ml) and prolactin (PRL, 173?ng/ml). She was known to take levosulpiride. The gonadotropin levels did not fit with the clinical features.Results: A gonadotroph tumor was ruled out. Further analysis confirmed constantly high FSH, LH and PRL levels. The measurements were repeated using different analytical platforms with different results. After serial dilutions, nonlinearity was present suggesting an immunoassay interference. After post-polyethylene glycol recovery, hormone levels appeared in the normal range. Anti-goat antibodies were recognized in the serum of the patient.Conclusions: This case report shows a case of falsely abnormal high gonadotropin and PRL levels in a woman during menopause transition. In the clinical practice the evaluation of gonadotropin profile is not recommended at this age, but the abnormal levels stimulated further evaluation. An interference in the assay due to anti-goat antibodies resulted in abnormally high level of FSH and LH. A strict collaboration between clinicians and the laboratory is needed, when laboratory findings do not correspond to clinical findings. 相似文献
45.
T. Wu L. G. Trahair M. J. Bound C. F. Deacon M. Horowitz C. K. Rayner K. L. Jones 《Diabetic medicine》2015,32(5):595-600
46.
47.
Weiyu Ye Anna Olsson-Brown Robert A. Watson Vincent T. F. Cheung Robert D. Morgan Isar Nassiri Rosalin Cooper Chelsea A. Taylor Umair Akbani Oliver Brain Rubeta N. Matin Nicholas Coupe Mark R. Middleton Mark Coles Joseph J. Sacco Miranda J. Payne Benjamin P. Fairfax 《British journal of cancer》2021,124(10):1661
Background Immune checkpoint blockers (ICBs) activate CD8+ T cells, eliciting both anti-cancer activity and immune-related adverse events (irAEs). The relationship of irAEs with baseline parameters and clinical outcome is unclear.Methods Retrospective evaluation of irAEs on survival was performed across primary (N = 144) and secondary (N = 211) independent cohorts of patients with metastatic melanoma receiving single agent (pembrolizumab/nivolumab—sICB) or combination (nivolumab and ipilimumab—cICB) checkpoint blockade. RNA from pre-treatment and post-treatment CD8+ T cells was sequenced and differential gene expression according to irAE development assessed.Results 58.3% of patients developed early irAEs and this was associated with longer progression-free (PFS) and overall survival (OS) across both cohorts (log-rank test, OS: P < 0.0001). Median survival for patients without irAEs was 16.6 months (95% CI: 10.9–33.4) versus not-reached (P = 2.8 × 10−6). Pre-treatment monocyte and neutrophil counts, but not BMI, were additional predictors of clinical outcome. Differential expression of numerous gene pathway members was observed in CD8+ T cells according to irAE development, and patients not developing irAEs demonstrating upregulated CXCR1 pre- and post-treatment.Conclusions Early irAE development post-ICB is associated with favourable survival in MM. Development of irAEs is coupled to expression of numerous gene pathways, suggesting irAE development in-part reflects baseline immune activation.Subject terms: Immunotherapy, Melanoma 相似文献
48.
49.
50.